Ananthakrishnan AN. Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep 2013;15:302.
Cosnes J, Gower-Rousseau C, Seksik P et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011;140:1785–1794.
Joossens M, Simoens M, Vermeire S et al. Contribution of genetic and environmental factors in the pathogenesis of Crohn’s disease in a large family with multiple cases. Inflamm Bowel Dis 2007;13:580–584.
De Vroey B, De Cassan C, Gower-Rousseau C et al. Editorial: Antibiotics earlier, IBD later? Am J Gastroenterol 2010;105:2693–2696.
Manichanh C, Borruel N, Casellas F et al. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012;9:599–608.
Gevers D, Kugathasan S, Denson LA et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 2014;15:382–392.
Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006;130:1588–1594.
Gilat T, Hacohen D, Lilos P et al. Childhood factors in ulcerative colitis and Crohn’s disease. an international cooperative study. Scand J Gastroenterol 1987;22:1009–1024.
Hildebrand H, Malmborg P, Askling J et al. Early-life exposures associated with antibiotic use and risk of subsequent Crohn’s disease. Scand J Gastroenterol 2008;43:961–966.
Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011;60:49–54.
Kronman MP, Zaoutis TE, Haynes K et al. Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics 2012;130:e794–e803.
Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn’s disease and ulcerative colitis. Am J Gastroenterol 2011;106:2133–2142.
Gearry RB, Richardson AK, Frampton CM et al. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010;25:325–333.
Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 2010;105:2687–2692.
Virta L, Auvinen A, Helenius H et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn’s disease—a nationwide, register-based Finnish case-control study. Am J Epidemiol 2012;175:775–784.
Card T, Logan RF, Rodrigues LC et al. Antibiotic use and the development of Crohn’s disease. Gut 2004;53:246–250.
Margolis DJ, Fanelli M, Hoffstad O et al. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am J Gastroenterol 2010;105:2610–2616.
Castiglione F, Diaferia M, Morace F et al. Risk factors for inflammatory bowel diseases according to the “hygiene hypothesis”: a case-control, multi-centre, prospective study in southern Italy. J Crohns Colitis 2012;6:324–329.
Van Kruiningen HJ, Joossens M, Vermeire S et al. Environmental factors in familial Crohn’s disease in Belgium. Inflamm Bowel Dis 2005;11:360–365.
Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008–2012.
Wells GA, Shea B, O’Connell D et alThe Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses Accessed June 2013 at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
Amre DK, Lambrette P, Law L et al. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn’s disease: a case-control study. Am J Gastroenterol 2006;101:1005–1011.
Ruemmele FM, El Khoury MG, Talbotec C et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr. 2006;43:603–609.
Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci 1994;39:555–560.
Lee TW, Russell L, Deng M et al. Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad. Intern Med J 2013;43:919–926.
Kappelman M, Froslev T, Erichsen R et al. Early life exposure to antibiotics and subsequent risk of Crohn’s Disease: A Danish National Birth Cohort. Gastroenterology 2012;42(Suppl 1):S–716.
Han DY, Fraser AG, Dryland P et al. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn’s disease within New Zealand. Mutat Res 2010;690:116–122.
Dethlefsen L, Huse S, Sogin ML et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6:e280.
Perez-Cobas AE, Gosalbes MJ, Friedrichs A et al. Gut microbiota disturbance during antibiotics therapy: a multi-omic approach. Gut 2013;62:1591–1601.
Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011;108:4554–4561.
Jakobsson HE, Jernberg C, Andersson AF et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010;5:e9836.
Gophna U, Sommerfeld K, Gophna S et al. Differences between tissue-associated intestinal microfloras of patients with Crohn’s disease and ulcerative colitis. J Clin Microbiol 2006;44:4136–4141.
Morgan XC, Tickle TL, Sokol H et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012;13:R79.
Yatsunenko T, Rey FE, Manary MJ et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222–227.
Khan KJ, Ullman TA, Ford AC et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011;106:661–673.
Wlodarska M, Willing B, Keeney KM et al. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun 2011;79:1536–1545.
Newtown DF, Macfarlane S, Macfarlane GT. Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms. Antimicrob Agents Chemother 2013;57:2016–2025.
Krook A. Effect of metronidazole and sulfasalazine on the normal human faecal flora. Scand J Gastroenterol 1981;16:587–592.
Porter CK, Tribble DR, Aliaga PA et al. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 2008;135:781–786.
Gradel KO, Nielsen HL, Schonheyder HC et al. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 2009;137:495–501.
Jess T, Simonsen J, Nielsen NM et al. Enteric salmonella or campylobacter infections and the risk of inflammatory bowel disease. Gut 2011;60:318–324.
Jostins L, Ripke S, Weersma RK et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119–124.
Kuo CH, Kuo HF, Huang CH et al. Early life exposure to antibiotics and the risk of childhood allergic diseases: an update from the perspective of the hygiene hypothesis. J Microbiol Immunol Infect 2013;46:320–329.
Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the ‘hygiene hypothesis’: too clean to be true? Br J Dermatol 2005;152:202–216.
Marild K, Ye W, Lebwohl B et al. Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol 2013;13:109.